Goralatide, Hematopoietic progenitor cell cycle inhibitor (ab141185)

Overview

  • Product name

    Goralatide, Hematopoietic progenitor cell cycle inhibitor
  • Description

    Hematopoietic progenitor cell cycle inhibitor
  • Alternative names

    • AcSDKP
    • Goralatide
  • Biological description

    Hematopoietic progenitor cell cycle inhibitor. Protects against chemotherapy in normal hematopoietic cells. In vivo.
  • Purity

    > 90%
  • CAS Number

    120081-14-3
  • Chemical structure

    Chemical Structure

Properties

References

This product has been referenced in:

  • Suzuki Y  et al. Establishment and clinical application of a highly sensitive enzyme immunoassay for determination of N-acetyl-seryl-aspartyl-lysyl-proline. J Pept Sci 18:276-81 (2012). Read more (PubMed: 22396066) »
  • Comte L  et al. In vivo modifications of AcSDKP metabolism and haematopoiesis in mice treated with 5-fluorouracil and Goralatide. Eur J Clin Invest 28:856-63 (1998). Read more (PubMed: 9793000) »
  • Wierenga PK & Konings AW Goralatide (AcSDKP) selectively protects murine hematopoietic progenitors and stem cells against hyperthermic damage. Exp Hematol 24:246-52 (1996). Read more (PubMed: 8641348) »

Customer reviews and Q&As

There are currently no Customer reviews or Questions for ab141185.
Please use the links above to contact us or submit feedback about this product.

Please note: All products are "FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC PROCEDURES, NOT FOR USE IN HUMANS"
For licensing inquiries, please contact partnerships@abcam.com

Sign up